New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for la ...

Senators on Monday called out the Philippine Statistics Authority for its slow response to fraudulent registration records of foreign nationals in the country.

Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...

Objective To present updated integrated safety analyses of bimekizumab in patients with axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA). Methods Safety data pooled from six phase IIb/III ...

UCB, a global biopharmaceutical company, today announced positive topline data from the BE BOLD trial assessing BIMZELX® (bimekizumab) versus SKYRIZI® (risankizumab) in adults with active psoriatic ...

STMicroelectronics’ new STM32 series redefines entry-level microcontroller performance and value for smart devices everywhereSTM32C5 with ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...

Free prostate cancer screening for men 40+ on Saturday, March 21, 10 a.m.–2 p.m. at Pike County Health Department in Troy; walk-ins only, no appointments needed.

Significantly more patients treated with once-daily, oral Sotyktu achieved an ACR20 response compared with placebo at Week 16 in the pivotal Phase 3 POETYK PsA-1 and POETYK PsA-2 clinical ...

FDA approval introduces first-in-class, once-daily oral TYK2 inhibition for active psoriatic arthritis, expanding deucravacitinib beyond its 2022 plaque psoriasis indication. POETYK PsA-1 and PsA-2 ...

When Team USA won gold medals in men's and women's hockey at the 2026 Winter Olympics in Milan-Cortina, the achievement ...

As the 2026 FIFA World Cup approaches in June, collectors focus on 18-year-old Brazilian phenom Estêvão Willian. This Chelsea ...